Newsroom

Real People. Real Stories.

Crippling drug prices have quickly become one of the hottest topics in health care. Consumers, patients, state budgets and public programs are feeling the burden, and reports show that we’re just getting started.

Read more

Statement on President Obama’s FY 2017 Proposed Budget

“Today the president took an important step in his FY 2017 Budget to support transparency in the market and provide new information to consumers. CSRxP welcomes this step and encourages Congress and the Administration to take action to make prescription drugs affordable for all Americans.”

Read more

Prescription drug costs are bigger problem than Martin Shkreli

Daraprim’s price hike was outrageous. But prices on prescriptions that are more widely used also continue to climb. Since the beginning of January, pharmaceutical giant Pfizer has raised prices on more than 100 of its prescription drugs, according to Reuters. Some of those drugs, like medicines used to help treat symptoms of menopause or combat seizures, went up by more than 20 percent. What’s more, Pfizer did not reduce the price of any prescriptions.

Read more

John Rother Statement on House Oversight Committee Hearing

“Prescription drug cost hikes are not limited to companies run by people like Martin Shkreli; they are commonplace in the pharmaceutical industry. This issue transcends political party lines because consumers, patients, and public programs across the country simply cannot afford higher prices for medication.”

Read more